Healthcare -
Biotechnology - NASDAQ - US
$ 19.935
-0.722 %
$ 1.58 B
Market Cap
-4.61
P/E
VRDN - SHORT-TERM INVESTMENTS
Short-term Investments VRDN - Viridian Therapeutics, Inc.
375 M
LAST VALUE
55.62%
2 YEAR CAGR
65.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR